BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Artlett CM, Thacker JD. Molecular activation of the NLRP3 Inflammasome in fibrosis: common threads linking divergent fibrogenic diseases. Antioxid Redox Signal 2015;22:1162-75. [PMID: 25329971 DOI: 10.1089/ars.2014.6148] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Inzaugarat ME, Johnson CD, Holtmann TM, McGeough MD, Trautwein C, Papouchado BG, Schwabe R, Hoffman HM, Wree A, Feldstein AE. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice. Hepatology 2019;69:845-59. [PMID: 30180270 DOI: 10.1002/hep.30252] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 17.0] [Reference Citation Analysis]
2 Gan W, Ren J, Li T, Lv S, Li C, Liu Z, Yang M. The SGK1 inhibitor EMD638683, prevents Angiotensin II–induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:1-10. [DOI: 10.1016/j.bbadis.2017.10.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 12.8] [Reference Citation Analysis]
3 Pinar AA, Yuferov A, Gaspari TA, Samuel CS. Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1. Front Pharmacol 2020;11:1201. [PMID: 32848798 DOI: 10.3389/fphar.2020.01201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Song Z, Gong Q, Guo J. Pyroptosis: Mechanisms and Links with Fibrosis. Cells 2021;10:3509. [PMID: 34944017 DOI: 10.3390/cells10123509] [Reference Citation Analysis]
5 Guo H, Bi X, Zhou P, Zhu S, Ding W. NLRP3 Deficiency Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in a Mouse Unilateral Ureteral Obstruction Model of Chronic Kidney Disease. Mediators Inflamm 2017;2017:8316560. [PMID: 28348462 DOI: 10.1155/2017/8316560] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
6 Meng N, Xia M, Lu YQ, Wang M, Boini KM, Li PL, Tang WX. Activation of NLRP3 inflammasomes in mouse hepatic stellate cells during Schistosoma J. infection. Oncotarget 2016;7:39316-31. [PMID: 27322427 DOI: 10.18632/oncotarget.10044] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
7 Park SY, Kang MJ, Jin N, Lee SY, Lee YY, Jo S, Eom JY, Han H, Chung SI, Jang K, Kim TH, Park J, Han JS. House dust mite-induced Akt-ERK1/2-C/EBP beta pathway triggers CCL20-mediated inflammation and epithelial-mesenchymal transition for airway remodeling. FASEB J 2022;36:e22452. [PMID: 35916017 DOI: 10.1096/fj.202200150RR] [Reference Citation Analysis]
8 Cao W, Wang X, Li J, Yan M, Chang CH, Kim J, Jiang J, Liao YP, Tseng S, Kusumoputro S, Lau C, Huang M, Han P, Lu P, Xia T. NLRP3 inflammasome activation determines the fibrogenic potential of PM2.5 air pollution particles in the lung. J Environ Sci (China) 2022;111:429-41. [PMID: 34949371 DOI: 10.1016/j.jes.2021.04.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
9 Li PL. Cardiovascular pathobiology of inflammasomes: inflammatory machinery and beyond. Antioxid Redox Signal 2015;22:1079-83. [PMID: 25779752 DOI: 10.1089/ars.2015.6319] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ge S, Yang W, Chen H, Yuan Q, Liu S, Zhao Y, Zhang J. MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs. Int J Mol Sci 2021;22:12413. [PMID: 34830293 DOI: 10.3390/ijms222212413] [Reference Citation Analysis]
11 Shi C, Yang H, Zhang Z. Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases. Front Cell Dev Biol 2020;8:139. [PMID: 32211410 DOI: 10.3389/fcell.2020.00139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
12 Kapetanaki S, Kumawat AK, Persson K, Demirel I. The Fibrotic Effects of TMAO on Human Renal Fibroblasts Is Mediated by NLRP3, Caspase-1 and the PERK/Akt/mTOR Pathway. Int J Mol Sci 2021;22:11864. [PMID: 34769294 DOI: 10.3390/ijms222111864] [Reference Citation Analysis]
13 Dong Z, Zhuang Q, Ning M, Wu S, Lu L, Wan X. Palmitic acid stimulates NLRP3 inflammasome activation through TLR4-NF-κB signal pathway in hepatic stellate cells. Ann Transl Med 2020;8:168. [PMID: 32309315 DOI: 10.21037/atm.2020.02.21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
14 Gutierrez A, Van Wagoner DR. Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update. J Cardiovasc Pharmacol 2015;66:523-9. [PMID: 26335221 DOI: 10.1097/FJC.0000000000000313] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
15 Vinaik R, Abdullahi A, Barayan D, Jeschke MG. NLRP3 inflammasome activity is required for wound healing after burns. Transl Res 2020;217:47-60. [PMID: 31843468 DOI: 10.1016/j.trsl.2019.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
16 Short WD, Wang X, Li H, Yu L, Kaul A, Calderon GA, Gilley J, Bollyky PL, Balaji S, Keswani SG. Interleukin-10 Producing T Lymphocytes Attenuate Dermal Scarring. Ann Surg 2021;274:627-36. [PMID: 34506318 DOI: 10.1097/SLA.0000000000004984] [Reference Citation Analysis]
17 González-Mariscal I, Pozo-Morales M, Romero-Zerbo SY, Espinosa-Jimenez V, Escamilla-Sánchez A, Sánchez-Salido L, Cobo-Vuilleumier N, Gauthier BR, Bermúdez-Silva FJ. Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage. Biomed Pharmacother 2022;145:112361. [PMID: 34872800 DOI: 10.1016/j.biopha.2021.112361] [Reference Citation Analysis]
18 Zhao X, Liu Y, Wang L, Yan C, Liu H, Zhang W, Zhao H, Cheng C, Chen Z, Xu T, Li K, Cai J, Qiao T. Oridonin Attenuates Hind Limb Ischemia-Reperfusion injury by modulating Nrf2-Mediated oxidative stress and NLRP3-Mediated inflammation. J Ethnopharmacol 2022;:115206. [PMID: 35301099 DOI: 10.1016/j.jep.2022.115206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Cannito S, Novo E, Parola M. Therapeutic pro-fibrogenic signaling pathways in fibroblasts. Adv Drug Deliv Rev 2017;121:57-84. [PMID: 28578015 DOI: 10.1016/j.addr.2017.05.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
20 Yu Y, Sun J, Wang R, Liu J, Wang P, Wang C. Curcumin Management of Myocardial Fibrosis and its Mechanisms of Action: A Review. Am J Chin Med 2019;47:1675-710. [PMID: 31786946 DOI: 10.1142/S0192415X19500861] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
21 Lu M, Li H, Liu W, Zhang X, Li L, Zhou H. Curcumin attenuates renal interstitial fibrosis by regulating autophagy and retaining mitochondrial function in unilateral ureteral obstruction rats. Basic Clin Pharmacol Toxicol 2021;128:594-604. [PMID: 33354908 DOI: 10.1111/bcpt.13550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Shen X, Dong X, Han Y, Li Y, Ding S, Zhang H, Sun Z, Yin Y, Li W, Li W. Ginsenoside Rg1 ameliorates glomerular fibrosis during kidney aging by inhibiting NOX4 and NLRP3 inflammasome activation in SAMP8 mice. Int Immunopharmacol 2020;82:106339. [PMID: 32114413 DOI: 10.1016/j.intimp.2020.106339] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
23 Conley SM, Abais JM, Boini KM, Li PL. Inflammasome Activation in Chronic Glomerular Diseases. Curr Drug Targets 2017;18:1019-29. [PMID: 27538510 DOI: 10.2174/1389450117666160817103435] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
24 Shen HH, Yang YX, Meng X, Luo XY, Li XM, Shuai ZW, Ye DQ, Pan HF. NLRP3: A promising therapeutic target for autoimmune diseases. Autoimmun Rev 2018;17:694-702. [PMID: 29729449 DOI: 10.1016/j.autrev.2018.01.020] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 23.0] [Reference Citation Analysis]
25 Chen Y, Ding S, Zhang H, Sun Z, Shen X, Sun L, Yin Y, Qun S, Li W. Protective effects of ginsenoside Rg1 on neuronal senescence due to inhibition of NOX2 and NLRP1 inflammasome activation in SAMP8 mice. Journal of Functional Foods 2020;65:103713. [DOI: 10.1016/j.jff.2019.103713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Liu C, Hu T, Cai Z, Xie Q, Yuan Y, Li N, Xie S, Yao Q, Zhao J, Wu QQ, Tang Q. Nucleotide-Binding Oligomerization Domain-Like Receptor 3 Deficiency Attenuated Isoproterenol-Induced Cardiac Fibrosis via Reactive Oxygen Species/High Mobility Group Box 1 Protein Axis. Front Cell Dev Biol 2020;8:713. [PMID: 32850832 DOI: 10.3389/fcell.2020.00713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Mangali S, Bhat A, Udumula MP, Dhar I, Sriram D, Dhar A. Inhibition of protein kinase R protects against palmitic acid-induced inflammation, oxidative stress, and apoptosis through the JNK/NF-kB/NLRP3 pathway in cultured H9C2 cardiomyocytes. J Cell Biochem 2019;120:3651-63. [PMID: 30259999 DOI: 10.1002/jcb.27643] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
28 Yuan X, Bhat OM, Meng N, Lohner H, Li PL. Protective Role of Autophagy in Nlrp3 Inflammasome Activation and Medial Thickening of Mouse Coronary Arteries. Am J Pathol 2018;188:2948-59. [PMID: 30273598 DOI: 10.1016/j.ajpath.2018.08.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
29 Li Y, Li H, Liu S, Pan P, Su X, Tan H, Wu D, Zhang L, Song C, Dai M, Li Q, Mao Z, Long Y, Hu Y, Hu C. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Mol Immunol 2018;99:134-44. [PMID: 29783158 DOI: 10.1016/j.molimm.2018.05.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 13.3] [Reference Citation Analysis]
30 Carson JP, Ramm GA, Robinson MW, McManus DP, Gobert GN. Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells. Trends Parasitol 2018;34:524-40. [PMID: 29526403 DOI: 10.1016/j.pt.2018.02.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
31 Bi X, Ai H, Wu Q, Fan Q, Ding F, Hu C, Ding W. Insulin Resistance Is Associated with Interleukin 1β (IL-1β) in Non-Diabetic Hemodialysis Patients. Med Sci Monit 2018;24:897-902. [PMID: 29436520 DOI: 10.12659/msm.906269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ferrari D, Gambari R, Idzko M, Müller T, Albanesi C, Pastore S, La Manna G, Robson SC, Cronstein B. Purinergic signaling in scarring. FASEB J 2016;30:3-12. [PMID: 26333425 DOI: 10.1096/fj.15-274563] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
33 Bi X, Chu M, Ai H, Hu C, Ding W. Association of serum IL-18 with protein-energy wasting in end-stage renal disease patients on haemodialysis. Int Urol Nephrol 2019;51:1271-8. [PMID: 31119516 DOI: 10.1007/s11255-019-02167-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Sun NN, Yu CH, Pan MX, Zhang Y, Zheng BJ, Yang QJ, Zheng ZM, Meng Y. Mir-21 Mediates the Inhibitory Effect of Ang (1-7) on AngII-induced NLRP3 Inflammasome Activation by Targeting Spry1 in lung fibroblasts. Sci Rep 2017;7:14369. [PMID: 29084974 DOI: 10.1038/s41598-017-13305-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
35 Sarhan M, Land WG, Tonnus W, Hugo CP, Linkermann A. Origin and Consequences of Necroinflammation. Physiol Rev 2018;98:727-80. [PMID: 29465288 DOI: 10.1152/physrev.00041.2016] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 18.3] [Reference Citation Analysis]